The authors of this article suggest that the combination of transcranial magnetic stimulation (TMS) and electroencephalography (EEG) may be used to identify distinct differences in Alzheimer’s Disease and MCI patients. They found that the TMS-EEG response P30 amplitude correlates with cognitive decline, with good specificity and sensitivity in differentiating between healthy subjects and those with MCI or AD.
Julkunen, P. Jauhiainen, AM. [and] Könönen, M. [et al] (2011). Combining transcranial magnetic stimulation and electroencephalography may contribute to assess the severity of Alzheimer’s disease. International Journal of Alzheimer’s Disease, May 15th 2011. (Click here to view the PubMed abstract).